Regenerative Aesthetics, Natural Results, and Where Fillers Still Fit

drpeter@venusmedical.ie (Dr Peter Prendergast) — Sat, 28 Mar 2026 18:56:46 GMT

As I look at what is genuinely shaping aesthetic medicine in 2026, the clearest shift is not toward doing more, but toward doing better. Patients are still interested in looking fresher and more confident, but the conversation has moved away from dramatic change and toward healthier skin, better tissue quality, subtle planning, and results that look natural.

The latest American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) trends report describes a move away from “dramatic, late-stage interventions and visibly overdone results” toward earlier, more strategic care focused on natural-looking outcomes, while non-invasive treatments still account for 80% of procedures. Globally, (International Society of Aesthetic Plastic Surgery) ISAPS reports that aesthetic procedures approached 38 million in 2024 (it's probably over 40M last year!), with botulinum toxin still the leading non-surgical treatment and hyaluronic acid fillers remaining firmly in second place.

That broader shift is one reason regenerative aesthetics has become such an important theme. More and more of the discussion is now about improving the quality and behaviour of tissue rather than simply filling or freezing lines. A recent 2026 narrative review describes regenerative aesthetics as a move from transient correction toward biologically driven tissue renewal, but it also makes an important point: the science is not uniform across all of these treatments. The evidence is promising in places, but it varies in quality, and there are still unresolved controversies, differences in durability, and regulatory questions across the different regenerative products now being talked about in clinic settings and on social media.

Exosomes are probably the most talked-about example of that trend. The interest is real: Aesthetic Surgery Journal has just published an April 2026 supplement devoted entirely to exosomes in aesthetic and regenerative medicine, which tells you how much attention the subject is getting from the specialty right now. For clarity, exosomes are completely different from ExoMind, the neurowellness technology also introduced at Venus Medical. In aesthetics, exosomes are being discussed in the context of skin quality, recovery, inflammation, and tissue signalling. It is an exciting area, but it is also one where enthusiasm has moved very quickly.

That is where I think patients deserve nuance rather than marketing. Exosomes may prove to be an important part of regenerative care, but at the moment they should still be viewed with caution and clinical judgement. The FDA says there are currently no FDA-approved exosome products and has warned that there is misleading information online about regenerative products, including exosomes. The recent literature takes a similarly careful tone, noting that exosome-based therapies in aesthetic medicine remain at an early stage, with major issues around standardisation, reproducibility, dosing, and regulation. In other words, the promise is real, but the evidence and regulation have not fully caught up with the hype. Our experience so far with these "boosters"? Positive for the most-part, with our patients reporting faster healing after skin procedures, more hydrated and brighter looking skin.

Polynucleotides are another major point of interest, and in my view they fit very well with the modern move toward skin quality and regeneration. Reviews of the literature describe polynucleotides as one of the more recent advances in regenerative aesthetic medicine, with growing evidence for improvements in skin texture, elasticity, hydration, and overall facial appearance. The concept of biostimulation and biorestructuring of the skin is certainly not new, though. In a book I edited 15 years ago, Aesthetic Medicine,we had a whole chapter on the subject. They are appealing because many patients today are not asking for a different face; they are asking for better skin, healthier tissue, and a more rested version of themselves. That said, polynucleotides are not magic, and they are not a replacement for every other tool. We see them as a powerful adjunct to almost every other cosmetic surgical or non-surgical procedure. Like muscle-relaxing injections, repeat treatments, say every 3-4 months, deliver most impressive skin rejuvenating results.

One area where I think the public conversation has become too simplistic is fillers. There is currently a strong “anti-filler” mood in parts of the aesthetic world, largely as a reaction to years of obvious, overfilled faces. That reaction is understandable, but it should not lead patients to believe that filler has no place in modern aesthetics. Poor filler is a problem; filler itself is not. Done conservatively, in selected patients, and in expert hands, fillers still play an important role in restoring age-related volume loss, supporting facial balance, and achieving very natural rejuvenation. AAFPRS members still report fillers as one of the most popular non-invasive treatments, ISAPS says hyaluronic acid filler procedures rose 5.2% globally to 6.3 million in 2024, and the FDA-approved uses of dermal fillers include augmentation of the cheeks, lips, and chin as well as correction of contour deficiencies. In other words, the real question is not filler or no filler — it is whether filler is being used for the right indication, in the right amount, by the right practitioner. The whole face can be addressed with judicious use of hyaluronic acid fillers for a natural, total facial rejuvenation.

Safety, of course, has to remain central to all of this. Here in Ireland, the HPRA reminds the public that dermal fillers are invasive procedures and that rare but severe complications can include blindness and stroke. It advises patients to go to a qualified and experienced healthcare professional and to ask about aftercare and complication management. The HPRA also highlighted a 2025 UK warning linked to adverse reactions after cosmetic procedures involving an unlicensed Botox-like product, underlining a point I make often: the product, the prescriber, the injector, and the setting all matter. Trends come and go, but anatomy, judgement, safety, and aftercare never go out of fashion.

For me, the future of aesthetics is not about choosing between regenerative medicine and fillers, or between devices and surgery, or between “natural” and “effective.” The future is intelligent combination treatment: understanding what the patient actually needs, improving tissue quality where appropriate, restoring structure when it has genuinely been lost, and always aiming for results that are elegant, believable, and individual. The best aesthetic work should never make someone look treated. It should make them look well.

Adept Medical blog

Regenerative Aesthetics, Natural Results, and Where Fillers Still Fit